AMGN

AMGN Biotechnology LLY Uncategorized

Amgen upgraded to buy at UBS on potential of MariTide, olpasiran

Jan 6, 2026

AMGN Biotechnology Uncategorized

Amgen acquires Dark Blue Therapeutics for up to $840 million

Jan 6, 2026

ABBV AMGN AZN Biotechnology BMY GILD GSK JNJ LLY MKGAF MRK NVO NVS PFE REGN SNY Uncategorized

More pharmas expected to sign drug pricing deals with Trump on Friday – report

Dec 17, 2025

AMGN Biotechnology Uncategorized

Amgen granted FDA nod for Uplizna in myasthenia gravis

Dec 12, 2025